Picossecond laser with a combination of seruns to treat dark skinned women with melasma

Zagonel, L.; Rocha, C.A.; Stoliar, F.F.M.; Vilhena, M.; Campos, V.

  • 10min
  • Feb. 2024
  • Supported by
  • SkinCeuticals

BACKGROUND

Melasma is a common dermatological condition (1). It is observed in all skin types, although it disproportionately affects dark skinned women. Some 30% to 50% of Latin Americans and Asians, among other races, can present (2). It can significantly impact the quality of life and patients have a reduced self-steem and a high incidence of depressive and anxiety disorders (3).

OBJECTIVE

Evaluate the efficacy of a combinated treatment with different seruns and picosecond laser in dark skinned female patiens.

INTRODUCTION

The treatment of melasma is one of the most challenging fields to dermatologists (4). It usually starts with preventions of sun, topical agents, oral therapies, chemical peels, microneedling, laser and light treatment. However, most have limited clinical efficacy, high rates of recurrence, and adverse reactions1. Topical hydroquinone alone or combinated with retinoid and a corticosteroid has the greatest evidence of efficacy (5), however not all patients tolerate the use and the safety has been established of daily use up to 12 months. These patients need safe options for long term treatment.
IMCAS 2024 Poster